Variant report
Variant | esv3529282 |
---|---|
Chromosome Location | chr8:115077726-115081749 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181816819 | chr8:115077730-115077731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs532717393 | chr8:115077741-115077742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201215080 | chr8:115077776-115077777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs139795011 | chr8:115077777-115077778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs57934127 | chr8:115077778-115077779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138307844 | chr8:115077807-115077808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs186461527 | chr8:115077812-115077813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs149220177 | chr8:115077857-115077858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548182166 | chr8:115077970-115077971 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568402156 | chr8:115078048-115078049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191637495 | chr8:115078087-115078088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530757838 | chr8:115078094-115078095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550461115 | chr8:115078142-115078143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547669671 | chr8:115078182-115078183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144561711 | chr8:115078192-115078193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539630069 | chr8:115078254-115078255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73706006 | chr8:115078282-115078283 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs11777624 | chr8:115078284-115078285 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs138549563 | chr8:115078392-115078393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183625607 | chr8:115078412-115078413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572005449 | chr8:115078494-115078495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs540598039 | chr8:115078527-115078528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560822582 | chr8:115078554-115078555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546014481 | chr8:115078580-115078581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374462390 | chr8:115078613-115078614 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs397518072 | chr8:115078614-115078615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs386728944 | chr8:115078615-115078616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370938173 | chr8:115078618-115078619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77449337 | chr8:115078619-115078620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76987013 | chr8:115078620-115078621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566473505 | chr8:115078664-115078665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77744368 | chr8:115078706-115078707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373202656 | chr8:115078735-115078736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75375325 | chr8:115078740-115078741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141622386 | chr8:115078749-115078750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531702396 | chr8:115078779-115078780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7833715 | chr8:115078780-115078781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs80020721 | chr8:115078821-115078822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573040101 | chr8:115078842-115078843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4266680 | chr8:115078878-115078879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs375912323 | chr8:115078909-115078910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540288077 | chr8:115078938-115078939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs368977074 | chr8:115079005-115079006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191321800 | chr8:115079030-115079031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs527665901 | chr8:115079036-115079037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145378973 | chr8:115079079-115079080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs116943549 | chr8:115079083-115079084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs533214431 | chr8:115079131-115079132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs28404904 | chr8:115079209-115079210 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs182748604 | chr8:115079229-115079230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autosomal-dominant progressive external ophthalmoplegia | 19664747 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21364760 | CNVD |
Neuroticism | 17667963 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Schizophrenia | 20967226 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:115077400-115083000 | Enhancers | Dnd41 | blood |
2 | chr8:115080600-115081200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr8:115080600-115081400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr8:115080800-115081200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr8:115080800-115081400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr8:115081200-115081400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr8:115081200-115086400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
8 | chr8:115081400-115086400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr8:115081400-115089200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |